ClinicalTrials.gg
RecruitingNCT07392944MOVE4CAREUpdated Feb 17, 2026

Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Homes (MOVE4CARE)

An interventional study of Multicomponent exercise intervention and stretching and relaxation program in Frailty and Dementia, sponsored by Universidade do Porto. Recruiting at 1 site in Portugal. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-17.

Sponsored by Universidade do Porto · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 5 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Can a multicomponent exercise program significantly improve physical and cognitive function and reduce fall rates among nursing home residents? To address this question, the present study aims to compare the effectiveness of a multicomponent exercise program with a stretching and relaxation program in nursing home residents.

Read the detailed description

Individuals residing in nursing homes commonly present with physical frailty and/or cognitive impairment. These geriatric syndromes are strongly associated with accelerated functional and cognitive decline, increased dependency, elevated fall risk, higher rates of hospitalization, and increased mortality. Accordingly, long-term care settings require evidence-based interventions capable of preserving functional capacity and cognitive performance while reducing fall incidence. Non-pharmacological approaches, particularly multicomponent exercise training, have demonstrated beneficial effects on physical and cognitive outcomes in institutionalized older adults. Nevertheless, existing evidence remains limited by methodological heterogeneity, underscoring the need for confirmation through rigorously designed randomized controlled trials. Therefore, this study proposes a 12-week randomized controlled trial in older adults living in nursing homes to evaluate the efficacy of a multicomponent exercise training program incorporating resistance and power, balance, and aerobic components on physical function, cognitive performance, and fall prevention.

The primary objective is to determine whether a multicomponent exercise program produces greater improvements in physical and cognitive function and larger reductions in fall rates compared with a stretching and relaxation program used as an active control. Secondary objectives are to assess whether intervention effects are sustained six weeks following program cessation and to examine the moderating influence of specific subgroups, including frail older adults and individuals with dementia, on intervention-related outcomes.

This study will be conducted as a 12-week assessor-blinded randomized controlled trial with a six-week post-intervention follow-up in nursing homes located in Vila Nova de Gaia, Porto District, Portugal. Participants will be randomly allocated to either a multicomponent exercise training group or an active control group. The intervention group will engage in supervised multicomponent exercise training twice weekly on nonconsecutive days to mitigate fatigue and overtraining. Each session will last 50 to 60 minutes and will comprise a standardized warm-up, progressive resistance and power exercises integrated with aerobic and balance training, followed by a cool-down period consisting of stretching and flexibility exercises. The exercise protocol will be aligned with the Global Consensus on Optimal Exercise recommendations for promoting healthy longevity in older adults. The active control group will participate in stretching, relaxation, and deep-breathing exercises, as well as low-intensity seated physical activities. Outcome assessments will be conducted at baseline, post-intervention at 12 weeks, and at follow-up at 18 weeks, with fall events prospectively monitored on a weekly basis throughout the study period.

02

Conditions studied

  • Frailty
  • Dementia

Keywords

  • Exercise
  • Frailty
  • Nursing homes
  • Multicomponent exercise
  • Falls
  • Cognitive function
  • Physical performance
03

In context

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

This study's planned enrollment of 60 is below the median of 83 across 772 interventional studies indexed under Frailty.

Browse Frailty studies →

Lead sponsor

Universidade do Porto is the lead sponsor of 174 studies on the registry; 53 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ability to ambulate (with or without assistance);
  • Ability to perform chair stands (with or without assistance);
  • Ability to understand and properly follow testing procedures.

Exclusion criteria

Exclusion Criteria:

  • Any that precludes exercise performance or testing procedures, including terminal illness, uncontrolled disease, or other unstable medical conditions;
  • Short Physical Performance Battery (SPPB) score \< 3 points;
  • Participation in any exercise intervention within the past 3 months;
  • Simultaneous participation in another clinical trial during the study;
  • Planned transfer to another nursing home facility, to home, or to hospitalization during the intervention.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Multicomponent exercise

    Supervised multicomponent exercise training.

    Other: Multicomponent exercise intervention

  • Active comparator
    stretching and relaxation program

    Stretches, deep breathing and relaxation exercises

    Other: stretching and relaxation program

Interventions

  • OtherMulticomponent exercise intervention

    Twice-weekly for the 12-week duration. The exercise intervention will take place at the nursing homes and consists of 12 weeks of supervised multicomponent exercise training, performed twice weekly on nonconsecutive days to avoid overtraining and fatigue. Each session will last 50-60 min and consist of a warm-up, progressive resistance and power exercises combined with aerobic and balance activities, and a 5-min cool-down period (stretching and flexibility movements). The exercise protocol will follow the Global Consensus on Optimal Exercise recommendations for enhancing healthy longevity in older adults.

  • Otherstretching and relaxation program

    Twice-weekly for the 12-week duration. The active control Program consist of stretches, deep breathing and relaxation techniques, general (light intensity) physical activity in the sitting position.

06

What researchers measure

Primary outcomes

  1. Change from Baseline on Short Physical Performance Battery (SPBB)

    The Short Physical Performance Battery (SPPB) is a standardized assessment tool of lower limb function, testing 3 dimensions: standing balance, walking speed, and chair stands. Each component is scored between 0-4, total score from 0 (poor performance) to 12 (best performance).

    Time frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up

Secondary outcomes

  1. Change from Baseline on Timed Up and Go (TUG)

    The Timed Up and Go (TUG) is a standardized assessment of functional mobility. Briefly, the participants will be instructed to rise from a chair, walk 3 meters at their usual pace, turn around, walk back to the chair, and sit down. The time taken to complete the task will be recorded and used as outcome, with longer durations representing poorer functional mobility.

    Time frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up

  2. Change from Baseline on Handgrip test

    Handgrip strength will be obtained with a Digital hand dynamometer (Sammons Preston Inc., Bolingbrook, Illinois, USA). Measurements will be carried out following the American Society of Hand Therapists recommendations, and each participant will perform three attempts with a pause of 15s between trials

    Time frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up

  3. Falls rate

    The number of self-reported falls during the 12-week intervention period (i.e., rate of falls) and follow-up (without intervention).

    Time frame: Weekly tracking over 18-week study period

  4. Change from baseline in global cognitive function as measured by the Montreal Cognitive Assessment (MoCA)

    The Montreal Cognitive Assessment (MoCA) is a brief, standardized cognitive screening tool, that assesses multiple cognitive domains (global cognitive function), including attention, executive functions, memory, language, visuospatial abilities, abstraction, calculation, and orientation. The test consists of a 30-point scale and typically requires approximately 10 minutes to administer. Higher scores indicate better cognitive performance.

    Time frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up

  5. Change from baseline in executive functions as measured by the Trail Making Test (Part A) and Digit Substitution Symbol Test

    The Trail Making Test Part A (TMT-A) is a widely used neuropsychological measure of visual attention, processing speed, and psychomotor function. Participants are required to connect numbered circles in sequential order as quickly and accurately as possible. Performance is typically scored by completion time in seconds, with longer times indicating poorer performance. The Digit Symbol Substitution Test (DSST) is a standardized measure of processing speed, attention, working memory, and visuomotor coordination. Participants are asked to match symbols to corresponding numbers according to a reference key within a fixed time (90 seconds). The total number of correct substitutions constitutes the outcome measure, with higher scores reflecting better cognitive performance

    Time frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up

  6. Change from baseline in mood as measured by the Geriatric Depression Scale

    The short-version of the Geriatric Depression Scale (GDS-15) is a brief, screening instrument designed to identify depressive symptoms. The total score ranges from 0 to 15, with higher scores indicating greater depressive symptom severity.

    Time frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up

07

Study locations

1 of 1 sites recruiting
  • Faculty of Sports, University of Porto
    Porto, 4000, Portugal
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2026; primary completion for May 2026, 3 months later.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 3 months is below that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 29, 2026
First posted
Feb 6, 2026
StartEst.
Feb 18, 2026
Primary completionEst.
May 29, 2026
CompletionEst.
Jul 31, 2026
Last update
Feb 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07392944
Responsible party
Sponsor
First posted
Feb 6, 2026
Start date
Feb 18, 2026 (estimated)
Primary completion
May 29, 2026 (estimated)
Completion
Jul 31, 2026 (estimated)
Last update
Feb 17, 2026

Study contacts

Maria Joana Carvalho, PhD
Contact
Jcarvalho@fade.up.pt
+351 220425316
Maria Joana Carvalho, PhD
principal investigator · Universidade do Porto

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion